Radiotherapy combined with immunotherapy for esophageal cancer: current status and challenge
Journal of Cancer Research and Clinical Oncology · 02.05.2026 · 152 (5)
DOI: 10.1007/s00432-026-06480-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 02.05.2026. Verfasst von Yuqing Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
With the advent of the immunotherapy era, the combination of radiotherapy and immunotherapy has become a critical strategy to enhance patient outcomes. In addition to its direct cytotoxicity, radiotherapy modulates the immune response within the tumor and its surrounding microenvironment by stimulating the body's anti-tumor immune response. This interplay provides the rationale for combining radiotherapy with immunotherapy. This review will summarize the immunomodulatory mechanisms of radiation therapy, evaluate the clinical efficacy and safety of combining radiotherapy with immunotherapy, and outline its current applications, challenges, and future potential. In the future, the combination of radiotherapy and immunotherapy holds immense potential in esophageal cancer treatment. Through additional prospective clinical trials exploring optimal combinations, timing, and biomarkers, we can further refine treatment strategies and enhance patient survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- The First School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. sunxinchen@njmu.edu.cn.
- The First School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China. sunxinchen@njmu.edu.cn.
Zitieren
APA
Wang, Y., Gu, J., & Sun, X. (2026). Radiotherapy combined with immunotherapy for esophageal cancer: current status and challenge. Journal of Cancer Research and Clinical Oncology, 152(5). https://doi.org/10.1007/s00432-026-06480-2
Vancouver
Wang Y, Gu J, Sun X. Radiotherapy combined with immunotherapy for esophageal cancer: current status and challenge. Journal of Cancer Research and Clinical Oncology. 2026;152(5). doi:10.1007/s00432-026-06480-2
BibTeX
@article{Wang2026,
author = {Wang, Yuqing and Gu, Junjie and Sun, Xinchen},
title = {Radiotherapy combined with immunotherapy for esophageal cancer: current status and challenge},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2026},
volume = {152},
number = {5},
doi = {10.1007/s00432-026-06480-2}
}
EUVIMED